383 — Tian An Medicare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.12bn
- HK$1.32bn
- HK$1.64bn
Annual cashflow statement for Tian An Medicare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -110 | -117 | 35.4 | 57 | — |
| Depreciation | |||||
| Non-Cash Items | 170 | 141 | 40.8 | 67.1 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 55 | -57.9 | 182 | -115 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 219 | 70.4 | 356 | 106 | — |
| Capital Expenditures | -154 | -138 | -198 | -193 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.6 | 39.3 | 19.2 | 58.3 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -185 | -98.6 | -179 | -135 | — |
| Financing Cash Flow Items | — | -59 | -47.8 | -34.2 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -79.1 | 29.9 | 101 | 29.1 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -40 | 12.6 | 301 | -4.84 | — |